Clinical trial
Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral…
NCT02928497 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT02928497 |
|---|---|
| Title | Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation |
| Official title | Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO) |
| Acronym | ASAP-TOO |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Stroke |
| Intervention type | Device, Drug |
| Interventions | WATCHMAN LAAC Device Implant, Single Antiplatelet Therapy or No Therapy (Control) |
| Enrollment | 481 |
| Start date | Feb 6, 2017 |
| Primary completion | Sep 23, 2025 |
| Completion | Sep 23, 2025 |
| First posted | Oct 10, 2016 |
| Last update posted | Jan 20, 2026 |
| Countries | Belgium, Canada, Czechia, Denmark, Germany, Italy, Netherlands, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: